Funding
Cancer
ONCOLOGY, CANCER
The CHARIOT trial was sponsored by the University of Oxford. Trial management was provided by the Oncology Clinical Trials Office (OCTO) at the University of Oxford as part of the UKCRC Oxford Clinical Trials Research Unit (OCTRU). This work was funded by Cancer Research UK (C43735/A20874). Additional financial support was provided by Merck KGaA, who also supplied berzosertib free of charge.